Displaying 409 - 420 of 452
General Hepatology
6

Alexion: My Patient Care vs Restricted Access to Medicines - The International Liver Congress™ 2019

View
General Hepatology
6

Alexion: My Patient Care vs Restricted Access to Medicines - The International Liver Congress™ 2019

View
General Hepatology
6

Alexion: My Patient Care vs Restricted Access to Medicines - The International Liver Congress™ 2019

View
General Hepatology
6

Alexion: My Patient Care vs Restricted Access to Medicines - The International Liver Congress™ 2019

View
Viral Hepatitis
4

AbbVie: How Can We Accelerate HCV Elimination in the Current Landscape? - Digital ILC 2020

View
Viral Hepatitis
4

AbbVie: How Can We Accelerate HCV Elimination in the Current Landscape? - Digital ILC 2020

View
Viral Hepatitis
4

AbbVie: How Can We Accelerate HCV Elimination in the Current Landscape? - Digital ILC 2020

View
Viral Hepatitis
4

AbbVie: How Can We Accelerate HCV Elimination in the Current Landscape? - Digital ILC 2020

View
Immune-Mediated and Cholestatic Diseases
1

Albireo: Challenges in the Management of Patients with Cholestatic Liver Diseases - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
4

Intercept: Emerging trends in the care pathway for patients with NASH - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
4

Intercept: Emerging trends in the care pathway for patients with NASH - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
4

Intercept: Emerging trends in the care pathway for patients with NASH - Digital ILC 2020

View
Displaying 409 - 420 of 452